| Literature DB >> 15954175 |
Bart Van den Driessche1, Eddy L Esmans, Annemie Van der Linden, Walter Van Dongen, Evi Schaerlaken, Filip Lemière, Erwin Witters, Zwi Berneman.
Abstract
Rats were intravenously injected with a single high dose (10 mg/kg) of the alkylating agent melphalan in order to study DNA-adduct formation. Quantitation of a dGuo-melphalan adduct was done by isotope dilution mass spectrometry using capillary liquid chromatography/mass spectrometry (LC/MS) and [15N5]-labeled dGuo-melphalan as internal standard. DNA-adduct levels were studied in bone marrow, liver and kidney. The instrumental detection limit of the method was determined to be 900 fg (S/N 3, pure standard). These first results clearly show a 10 times higher adduct level in bone marrow compared to kidney and a 6 times higher level compared to liver. More experiments will be necessary to gather more information on the pharmacokinetics of melphalan-DNA adducts under in vivo conditions. Copyright (c) 2005 John Wiley & Sons, Ltd.Entities:
Mesh:
Substances:
Year: 2005 PMID: 15954175 DOI: 10.1002/rcm.2018
Source DB: PubMed Journal: Rapid Commun Mass Spectrom ISSN: 0951-4198 Impact factor: 2.419